Adagio Medical to go public through $128m SPAC merger with ARYA
Adagio Medical will become a subsidiary of Aja Holdco, which will operate with its existing management team under…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Feb 24
Adagio Medical will become a subsidiary of Aja Holdco, which will operate with its existing management team under…
08 Jan 24
GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic…
04 Jan 24
K Health will work with Mayo Clinic to develop and test its bespoke preventative cardiology care technology
29 Sep 23
CaRi-Heart® Users share Excitement on Potential for Heart Attack Prediction and Prevention
04 Sep 23
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited (Lupin), today announced the launch of Propranolol LA…
01 Sep 23
The ACTIMIS clinical trial evaluating glenzocimab in combination with the reference treatment in patients presenting with AIS has…
28 Aug 23
Two implants were successfully conducted as part of the FDA approved Early Feasibility Study in the United States
27 Jul 23
Reduction in blood oxygen levels, largely attributed to blocked airways, emerges as a leading factor.
02 Nov 22
The transaction, which has been unanimously approved by boards of directors of both companies, is expected to be…
22 Feb 22
The expanded FDA approval enables patients with Class II heart failure and elevated levels of natriuretic peptides to…